Serum protein profiles in carcinoma of the kidney.
The levels of serum acute phase reactant proteins (APRPs) have been examined in untreated kidney carcinoma and during the evolution of metastases. These proteins can provide a warning of the likelihood of extensive local or metastatic spread at first presentation. The levels of APRPs rise with increasing tumour burden but the system is insensitive to small tumour burdens. beta 2-Microglobulin levels do not contribute additional information. Serum phosphohexose isomerase tends to be elevated when there is a large tumour burden but its change does not accurately mirror the rate of expansion of the tumour. The APRPs and phosphohexose isomerase are useful in alerting the clinician to the probability of metastases or large local masses in kidney cancer, but have a limited use in monitoring.
D001798:Blood Proteins / Q000032:analysis*; D002097:C-Reactive Protein / Q000032:analysis; D002277:Carcinoma / Q000097:blood* / Q000556:secondary; D002918:Chymotrypsin / Q000032:analysis / Q000037:antagonists & inhibitors; D005260:Female; D005956:Glucose-6-Phosphate Isomerase / Q000097:blood; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood*; D008297:Male; D009961:Orosomucoid / Q000032:analysis; D011480:Protease Inhibitors / Q000032:analysis; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin / Q000032:analysis; D001613:beta 2-Microglobulin / Q000032:analysis
D001798:Blood Proteins; D006242:Haptoglobins; D009961:Orosomucoid; D011480:Protease Inhibitors; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin; D001613:beta 2-Microglobulin; D002097:C-Reactive Protein; D002918:Chymotrypsin; D005956:Glucose-6-Phosphate Isomerase